AstraZeneca Loses Bid To Nix Toprol Antitrust Suits
AstraZeneca Pharmaceuticals LP has lost its bid to toss a pair of consolidated class action complaints filed by Toprol-XL direct purchasers and end-payors accusing the pharmaceutical giant of trying to block...To view the full article, register now.
Already a subscriber? Click here to view full article